Cited by 191Opioid Use Disorder TreatmentPrenatal Substance Exposure EffectsPregnancy and Medication Impact

The DOI matches its Crossref record; 132 of the 137 references it cites were found in a registry or an index.

Treatment of opioid-dependent pregnant women: Clinical and research issues

Open access

Jones, Hendree E., Martin, Peter R., Heil, Sarah H., Kaltenbach, Karol, Selby, Peter, Coyle, Mara G., Stine, Susan M., O'Grady, Kevin E., Arria, Amelia M., Fischer, Gabriele·2008·Journal of Substance Abuse Treatment

DOI 10.1016/j.jsat.2007.10.007PMC PMC2633026

Open this paper in CoChat — free account

Abstract

This article addresses common questions that clinicians face when treating pregnant women with opioid dependence. Guidance, based on both research evidence and the collective clinical experience of the authors, which include investigators in the Maternal Opioid Treatment: Human Experimental Research (MOTHER) project, is provided to aid clinical decision making. The MOTHER project is a double-blind, double-dummy, flexible-dosing, parallel-group clinical trial examining the comparative safety and efficacy of methadone and buprenorphine for the treatment of opioid dependence in pregnant women and their neonates. The article begins with a discussion of appropriate assessment during pregnancy and then addresses clinical management stages including maintenance medication selection, induction, and stabilization; opioid agonist medication management before, during, and after delivery; pain management; breast-feeding; and transfer to aftercare. Lastly, other important clinical issues including managing co-occurring psychiatric disorders and medication interactions are discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jsat.2007.10.007

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Fifth Edition of the Addiction Severity Index.
Mclellan, A., Kushner, H., Metzger, D., Peters, R., Smith, I. E., Grissom, G. R., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,280
Healthy People 2010
Yu, S. M. (1998) · Maternal and Child Health Journal · doi:10.1023/a:1021801927353 · Cited by 3,876
Avian Clinical Biochemistry
Lumeij, J. T. (1997) · Elsevier eBooks · doi:10.1016/b978-012396305-5/50031-2 · Cited by 1,185
The Clinical Opiate Withdrawal Scale (COWS)
Wesson, D. R., & Ling, W. W. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400007 · Cited by 1,120
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C., Hernández–Dı́az, S., Marter, L. J. V., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 877
A meta-analysis of voucher-based reinforcement therapy for substance use disorders
Lussier, J. P., Heil, S. H., Mongeon, J. A., Badger, G. J., & Higgins, S. T. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01311.x · Cited by 858
Self-citation
Mechanisms of fatal opioid overdose
White, J. M., & Irvine, R. J. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.9479612.x · Cited by 635
Interindividual Variability of the Clinical Pharmacokinetics of Methadone: Implications for the Treatment of Opioid Dependence
Eap, C. B., Buclin, T., & Baumann, P. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241140-00003 · Cited by 599
Effective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
Perinatal Risks of Untreated Depression during Pregnancy
Bonari, L., Pinto, N., Ahn, E., Einarson, A., Steiner, M. S., & Koren, G. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901103 · Cited by 534

Show all 137 references

Research works printed but not linked: 1

Gazaway, 1993, The influence of pregnancy upon trough plasma levels of methadone and its opioid effects, NIDA research monograph, 132, 112

Sorted by citations

Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005359 · Cited by 986
Self-citation
Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy
(2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002235 · Cited by 674
The Transfer of Drugs and Therapeutics Into Human Breast Milk: An Update on Selected Topics
Sachs, H. C., Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Johnson, T., Neville, K. A., Paul, I. M., & van den Anker, J. (2013) · PEDIATRICS · doi:10.1542/peds.2013-1985 · Cited by 594
Management of opioid use disorders: a national clinical practice guideline
Bruneau, J., Ahamad, K., Goyer, M.-È., Poulin, G., Selby, P. L., Fischer, B., Wild, T. C., & Wood, E. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.170958 · Cited by 412
Self-citation
Statement of the American Society of Addiction Medicine Consensus Panel on the Use of Buprenorphine in Office-Based Treatment of Opioid Addiction
Kraus, M. L., Alford, D. P., Kotz, M. M., Levounis, P., Mandell, T. W., Meyer, M. C., Salsitz, E. A., Wetterau, N., & Wyatt, S. A. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3182312983 · Cited by 265
Unintended pregnancy in opioid-abusing women
Heil, S. H., Jones, H. E., Arria, A. M., Kaltenbach, K. A., Coyle, M. G., Fischer, G., Stine, S. M., Selby, P. L., & Martin, P. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.08.011 · Cited by 264
Self-citation
The United States opioid epidemic
Lyden, J. R., & Binswanger, I. A. (2019) · Seminars in Perinatology · doi:10.1053/j.semperi.2019.01.001 · Cited by 262
Maintenance agonist treatments for opiate dependent pregnant women
Minozzi, S., Amato, L., Vecchi, S., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub2 · Cited by 225
From Generic to Gender-Responsive Treatment: Changes in Social Policies, Treatment Services, and Outcomes of Women in Substance Abuse Treatment
Grella, C. E. (2008) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2008.10400661 · Cited by 209
Buprenorphine treatment of opioid‐dependent pregnant women: a comprehensive review
Jones, H. E., Heil, S. H., Baewert, A., Arria, A. M., Kaltenbach, K. A., Martin, P., Coyle, M. G., Selby, P. L., Stine, S. M., & Fischer, G. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04035.x · Cited by 176
Self-citation
Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates
Winklbaur, B., Kopf, N., Ebner, N., Jung, E., Thau, K., & Fischer, G. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02283.x · Cited by 171
Self-citation
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy
Suarez, E. A., Huybrechts, K. F., Straub, L., Hernández–Dı́az, S., Jones, H. E., Connery, H. S., Davis, J. M., Gray, K. J., Lester, B. M., Terplan, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2203318 · Cited by 169
Self-citation
Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications.
Minnes, S., Lang, A., & Singer, L. T. (2011) · Europe PMC (PubMed Central) · Cited by 160
Management of psychotropic drugs during pregnancy
Chisolm, M. S., & Payne, J. L. (2016) · BMJ · doi:10.1136/bmj.h5918 · Cited by 137
Increasing pregnancy-related use of prescribed opioid analgesics
EPSTEIN, R. A., Bobo, W. V., Martin, P., Morrow, J. A., Wang, W., Chandrasekhar, R., & Cooper, W. O. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.05.017 · Cited by 128
Self-citation
Neonatal outcomes following in utero exposure to methadone or buprenorphine: A National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009
Welle-Strand, G. K., Skurtveit, S. O., Jones, H. E., Waal, H., Bakstad, B., Bjarkø, L., & Ravndal, E. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.001 · Cited by 123
Self-citation
Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers
Jones, H. E., Deppen, K., Hudak, M. L., Leffert, L. R., McClelland, C., Şahin, L., Starer, J., Terplan, M., Thorp, J. M., Walsh, J., et al. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.10.010 · Cited by 117
Self-citation
Maintenance agonist treatments for opiate-dependent pregnant women
Minozzi, S., Amato, L., Bellisario, C., Ferri, M., & Davoli, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub3 · Cited by 114
Management of injecting drug users admitted to hospital
Haber, P., Demirkol, A., Lange, K. J., & Murnion, B. P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61036-9 · Cited by 114
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence
Soyka, M., Kranzler, H. R., van den Brink, W., Krystal, J. H., Möller, H., Kasper, S. F., & The WFSBP Task Force on Treatment, G. F. S. U. D. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.561872 · Cited by 112
Unplanned pregnancy and contraceptive use in women attending drug treatment services
Black, K. I., Stephens, C., Haber, P., & Lintzeris, N. (2012) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2012.01413.x · Cited by 105
Buprenorphine and Naloxone Compared With Methadone Treatment in Pregnancy
Wiegand, S. L., Stringer, E. M., Stuebe, A. M., Jones, H. E., Seashore, C. J., & Thorp, J. M. (2015) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000640 · Cited by 102
Self-citation
Co‐occurring Psychiatric Symptoms Are Associated with Increased Psychological, Social, and Medical Impairment in Opioid Dependent Pregnant Women
Benningfield, M. M., Arria, A. M., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Fischer, G., Jones, H. E., & Martin, P. R. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00064.x · Cited by 96
Self-citation
Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment
Brown, J. D., Goodin, A. J., & Talbert, J. (2017) · The Journal of Rural Health · doi:10.1111/jrh.12251 · Cited by 95
Neonatal neurobehavior effects following buprenorphine versus methadone exposure
Coyle, M. G., Salisbury, A. L., Lester, B. M., Jones, H. E., Lin, H., Graf‐Rohrmeister, K., & Fischer, G. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04040.x · Cited by 92
Self-citation
Polysubstance Use Among US Women of Reproductive Age Who Use Opioids for Nonmedical Reasons
Jarlenski, M., Barry, C. L., Gollust, S. E., Graves, A. J., Kennedy‐Hendricks, A., & Kozhimannil, K. B. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303825 · Cited by 82
Prenatal and Postpartum Care of Women with Substance Use Disorders
Gopman, S. (2014) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2014.02.004 · Cited by 88
Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine
Unger, A., Jung, E., Winklbaur, B., & Fischer, G. (2010) · Journal of Addictive Diseases · doi:10.1080/10550881003684814 · Cited by 77
Self-citation
Methadone and Buprenorphine Toxicity in Children
Boyer, E. W., McCance‐Katz, E. F., & Marcus, S. M. (2009) · American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00002.x · Cited by 69
Fetal neurobehavioral effects of exposure to methadone or buprenorphine
Jansson, L. M., DiPietro, J. A., Vélez, M. L., Elko, A., Williams, E., Milio, L. A., O’Grady, K. E., & Jones, H. E. (2010) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2010.09.003 · Cited by 68
Self-citation
Improving Access to Maternity Care for Women with Opioid Use Disorders: Colocation of Midwifery Services at an Addiction Treatment Program
Goodman, D. (2015) · Journal of Midwifery & Women's Health · doi:10.1111/jmwh.12340 · Cited by 65
Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies
Bisaga, A. M., Mannelli, P., Sullivan, M. A., Vosburg, S. K., Compton, P. A., WOODY, G. E., & Kosten, T. R. (2018) · American Journal on Addictions · doi:10.1111/ajad.12711 · Cited by 63
Infant Birth Outcomes Among Substance Using Women: Why Quitting Smoking During Pregnancy is Just as Important as Quitting Illicit Drug Use
Bailey, B. A., McCook, J. G., Hodge, A., & McGrady, L. (2011) · Maternal and Child Health Journal · doi:10.1007/s10995-011-0776-y · Cited by 65
Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes
Benningfield, M. M., Dietrich, M. S., Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Fischer, G., et al. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04041.x · Cited by 60
Self-citation
Psychopharmacologic Management of Opioid‐Dependent Women during Pregnancy
Martin, P., Arria, A. M., Fischer, G., Kaltenbach, K. A., Heil, S. H., Stine, S. M., Coyle, M. G., Selby, P. L., & Jones, H. E. (2009) · American Journal on Addictions · doi:10.1080/10550490902772975 · Cited by 59
Self-citation
Maternal Buprenorphine Dose, Placenta Buprenorphine, and Metabolite Concentrations and Neonatal Outcomes
Concheiro, M., Jones, H. E., Johnson, R. E., Choo, R. E., Shakleya, D. M., & Huestis, M. A. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181d0bd68 · Cited by 59
Self-citation
Smoking in Pregnant Women Screened for an Opioid Agonist Medication Study Compared to Related Pregnant and Non-Pregnant Patient Samples
Jones, H. E., Heil, S. H., O’Grady, K. E., Martin, P. R., Kaltenbach, K. A., Coyle, M., Stine, S. M., Selby, P. L., Arria, A. M., & Fischer, G. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990903125235 · Cited by 56
Self-citation
Preliminary Buprenorphine Sublingual Tablet Pharmacokinetic Data in Plasma, Oral Fluid, and Sweat During Treatment of Opioid-Dependent Pregnant Women
Concheiro, M., Jones, H. E., Johnson, R. E., Choo, R. E., & Huestis, M. A. (2011) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318228bb2a · Cited by 53
Self-citation
Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings
Meinhofer, A., Hinde, J. M., & Ali, M. M. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.12.005 · Cited by 54
Maintenance agonist treatments for opiate-dependent pregnant women
Minozzi, S., Amato, L., Jahanfar, S., Bellisario, C., Ferri, M., & Davoli, M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub4 · Cited by 53
Drug use and pregnancy – challenges for public health
Gyarmathy, V. A., Giraudon, I., Hedrich, D., Montanari, L., Guarita, B., & Wiessing, L. G. (2009) · Eurosurveillance · doi:10.2807/ese.14.09.19142-en · Cited by 52
Impact of treatment approach on maternal and neonatal outcome in pregnant opioid‐maintained women
Metz, V. E., Jagsch, R., Ebner, N., Würzl, J., Pribasnig, A., Aschauer, C., & Fischer, G. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1224 · Cited by 52
Self-citation
Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid CrisisPreprint
Weller, A. E., Crist, R. C., Reiner, B. C., Doyle, G. A. R., & Berrettini, W. H. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039669 · Cited by 52
Developmental Consequences of Prenatal Substance Use in Children and Adolescents
Guille, C., & Aujla, R. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0177 · Cited by 49
Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
Jumah, N. A., Edwards, C., Balfour-Boehm, J., Loewen, K., Dooley, J., Gerber-Finn, L., & Kelly, L. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011774 · Cited by 45
The treatment of alcohol and opioid dependence in pregnant women
Heberlein, A., Leggio, L., Stichtenoth, D. O., & Hillemacher, T. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328358ad36 · Cited by 43
Psychosocial characteristics and poly-drug use of pregnant women enrolled in methadone maintenance treatment
Davie‐Gray, A., Moor, S., Spencer, C., & Woodward, L. J. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2013.04.006 · Cited by 42
Umbilical Cord Monitoring of In Utero Drug Exposure to Buprenorphine and Correlation with Maternal Dose and Neonatal Outcomes
Concheiro, M., Jones, H. E., Johnson, R. E., Choo, R. E., Shakleya, D. M., & Huestis, M. A. (2010) · Journal of Analytical Toxicology · doi:10.1093/jat/34.8.498 · Cited by 38
Self-citation
Prenatal opioid exposure and vulnerability to future substance use disorders in offspring
Abu, Y. F., & Roy, S. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113621 · Cited by 38
Effects of opioids on the parental brain in health and disease
Swain, J. E., Ho, S.-H. S., Fox, H. C., Garry, D. J., & Brummelte, S. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100766 · Cited by 38
Treatment of Opioid Dependence in the Setting of Pregnancy
Young, J. L., & Martin, P. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.03.008 · Cited by 35
Self-citation
Observational Study of Buprenorphine Treatment of Opioid-Dependent Pregnant Women in a Family Medicine Residency: Reports on Maternal and Infant Outcomes
O’Connor, A. B., Alto, W. A., Musgrave, K., Gibbons, D. C., Llanto, L., Holden, S., & Karnes, J. (2011) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2011.02.100155 · Cited by 35
Are Male Neonates More Vulnerable to Neonatal Abstinence Syndrome Than Female Neonates?
Unger, A., Jagsch, R., Bäwert, A., Winklbaur, B., Rohrmeister, K., Martin, P., Coyle, M. G., & Fischer, G. (2011) · Gender Medicine · doi:10.1016/j.genm.2011.10.001 · Cited by 34
Self-citation
Changes in methadone maintenance therapy during and after pregnancy
Albright, B. B., de la Torre, L., SKIPPER, B. J., Price, S., Abbott, P., & Rayburn, W. F. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.05.002 · Cited by 33
Neonatal abstinence syndrome: Neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal
Heller, N. A., Logan, B. A., Morrison, D. G., Paul, J. A., Brown, M. S., & Hayes, M. J. (2017) · Developmental Psychobiology · doi:10.1002/dev.21532 · Cited by 33
Pharmacological treatment of opioid use disorder in pregnancy
Rodriguez, C. E., & Klie, K. A. (2019) · Seminars in Perinatology · doi:10.1053/j.semperi.2019.01.003 · Cited by 32
A qualitative meta‐synthesis of pregnant women's experiences of accessing and receiving treatment for opioid use disorder
Tsuda‐McCaie, F., & Kotera, Y. (2022) · Drug and Alcohol Review · doi:10.1111/dar.13421 · Cited by 34
Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra‐individual comparison
Unger, A., Jagsch, R., Jones, H. E., Arria, A. M., Leitich, H., Rohrmeister, K., Aschauer, C., Winklbaur, B., Bäwert, A., & Fischer, G. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03440.x · Cited by 32
Self-citation
Management of women treated with buprenorphine during pregnancy
Alto, W. A., & O’Connor, A. B. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.04.001 · Cited by 31
Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment
Bachhuber, M. A., Mehta, P., Faherty, L. J., & Saloner, B. K. (2017) · Medical Care · doi:10.1097/mlr.0000000000000803 · Cited by 31
Pharmacological Management of Opioid Use Disorder in Pregnant Women
Wilder, C. M., & Winhusen, T. M. (2015) · CNS Drugs · doi:10.1007/s40263-015-0273-8 · Cited by 30
Maternal Opioid Exposure Culminates in Perturbed Murine Neurodevelopment and Hyperactive Phenotype in Adolescence
Schlagal, C. R., Dunn, T. J., Xu, P., Felsing, D. E., Merritt, C. R., Manja, S., Fox, R. G., Buffington, S. A., Saade, G. R., Dineley, K. T., et al. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.03.014 · Cited by 29
Development of a Substance Abuse Program for Opioid-Dependent Nonurban Pregnant Women Improves Outcome
Meyer, M. C., Benvenuto, A., Howard, D. B., Johnston, A., Plante, D., Metayer, J., & Mandell, T. W. (2012) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3182541933 · Cited by 29
Group Prenatal Care for Women Receiving Medication‐Assisted Treatment for Opioid Use Disorder in Pregnancy: An Interprofessional Approach
Sutter, M. B., Watson, H., Bauers, A., JOHNSON, K., Hatley, M., Yonke, N., & Leeman, L. M. (2019) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12960 · Cited by 28
Safe Management of Chronic Pain in Pregnancy in an Era of Opioid Misuse and Abuse
Pritham, U. A., & McKay, L. (2014) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/1552-6909.12487 · Cited by 28
First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations
Suarez, E. A., Bateman, B. T., Straub, L., Hernández–Dı́az, S., Jones, H. E., Gray, K. J., Connery, H. S., Davis, J. M., Lester, B. M., Terplan, M., et al. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.6986 · Cited by 29
Self-citation
Obstetrician-Gynecologists’ practice patterns related to opioid use during pregnancy and postpartum - United States, 2017
Ko, J. Y., Tong, V. T., Haight, S., Terplan, M., Snead, C. M., & Schulkin, J. (2019) · Journal of Perinatology · doi:10.1038/s41372-019-0535-2 · Cited by 23
Advances in animal models of prenatal opioid exposure
Ferrante, J. R., & Blendy, J. A. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.03.005 · Cited by 26
Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women
Concheiro, M., Jones, H. E., Johnson, R. E., Shakleya, D. M., & Huestis, M. A. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.11.005 · Cited by 26
Self-citation
Illicit drug use in pregnancy: effects and management
MADGULA, R., Groshkova, T., & Mayet, S. (2011) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.10.54 · Cited by 29
Pregnancy- and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them
Apsley, H. B., Brant, K., Brothers, S., Harrison, E., Skogseth, E. M., Schwartz, R. P., & Jones, A. A. (2024) · Women s Health · doi:10.1177/17455057231224181 · Cited by 23
“Subutex is safe”: Perceptions of risk in using illicit drugs during pregnancy
Leppo, A. (2012) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2012.01.004 · Cited by 24
Auricular acupuncture for chemically dependent pregnant women: a randomized controlled trial of the NADA protocol
Janssen, P. A., Demorest, L. C., Kelly, A. M., Thiessen, P. N., & Abrahams, R. (2012) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-7-48 · Cited by 24
Initiation and Engagement with Methadone Treatment among Pregnant and Postpartum Women
Mattocks, K. M., Clark, R. E., & Weinreb, L. (2017) · Women s Health Issues · doi:10.1016/j.whi.2017.05.002 · Cited by 24
Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?
Kelty, E. A., Terplan, M., Greenland, M., & Preen, D. B. (2021) · Drugs · doi:10.1007/s40265-021-01509-x · Cited by 25
Postpartum changes in methadone maintenance dose
Pace, C. A., Kaminetzky, L. B., Winter, M. R., Cheng, D. M., Saia, K., Samet, J. H., & Walley, A. Y. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.04.004 · Cited by 21
Opioid use disorder in pregnancy
Harter, K. (2019) · Mental Health Clinician · doi:10.9740/mhc.2019.11.359 · Cited by 21
Clinical Characteristics of Central European and North American Samples of Pregnant Women Screened for Opioid Agonist Treatment
Unger, A., Martin, P., Kaltenbach, K. A., Stine, S. M., Heil, S. H., Jones, H. E., Arria, A. M., Coyle, M. G., Selby, P. L., & Fischer, G. (2010) · European Addiction Research · doi:10.1159/000284683 · Cited by 21
Self-citation
Characteristics of Opioid-Using Pregnant Women Who Accept or Refuse Participation in a Clinical Trial: Screening Results from the MOTHER Study
Stine, S. M., Heil, S. H., Kaltenbach, K. A., Martin, P., Coyle, M. G., Fischer, G., Arria, A. M., Selby, P. L., & Jones, H. E. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990903374080 · Cited by 20
Self-citation
Opioid misuse as a coping behavior for unmet mental health needs among U.S. adults
Cruden, G., & Karmali, R. N. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108805 · Cited by 22
Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009
Welle-Strand, G. K., Skurtveit, S. O., Tanum, L., Waal, H., Bakstad, B., Bjarkø, L., & Ravndal, E. (2015) · European Addiction Research · doi:10.1159/000381670 · Cited by 20
Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
Gawronski, K. M., Prasad, M. R., Backes, C. R., Lehman, K. J., Gardner, D. K., & Cordero, L. (2014) · SAGE Open Medicine · doi:10.1177/2050312114530282 · Cited by 20
A Systematic Scoping Review of Peridelivery Pain Management for Pregnant People With Opioid Use Disorder: From the Society for Obstetric Anesthesia and Perinatology and Society for Maternal Fetal Medicine
Lim, G., Soens, M., Wanaselja, A., Chyan, A., Carvalho, B., Landau, R., George, R. B., Klem, M. L., Osmundson, S. S., Krans, E. E., et al. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006167 · Cited by 19
Evaluation and Management of Opioid Dependence in Pregnancy
Park, E. M., Meltzer-Brody, S. E., & Suzuki, J. (2012) · Psychosomatics · doi:10.1016/j.psym.2012.04.003 · Cited by 19
Maternal and neonatal characteristics of a Canadian urban cohort receiving treatment for opioid use disorder during pregnancy
Miller, C. D., Grynspan, D., Gaudet, L., Ferretti, E., Lawrence, S. L., Moretti, F., Lafreniere, A. J., McGee, A., Lattuca, S., & Black, A. (2018) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174418000478 · Cited by 19
Buprenorphine Use in Pregnant Opioid Users: A Critical Review
Soyka, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0072-z · Cited by 19
Developmental opioid exposures: Neurobiological underpinnings, behavioral impacts, and policy implications
Goldfarb, S. S., Stanwood, G. D., Flynn, H. A., & Graham, D. L. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219883601 · Cited by 18
Lessons learned from a comparison of evidence‐based research in pregnant opioid‐dependent women
Winklbaur, B., Jagsch, R., Graf‐Rohrmeister, K., Unger, A., Baewert, A., Langer, M., Thau, K., & Fischer, G. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2275 · Cited by 17
Self-citation
Initial Feasibility of a Woman-Focused Intervention for Pregnant African-American Women
Jones, H. E., Berkman, N. D., Kline, T., Ellerson, R. M., Browne, F. A., Poulton, W., & Wechsberg, W. M. (2011) · International Journal of Pediatrics · doi:10.1155/2011/389285 · Cited by 17
Self-citation
Medications for opioid use disorder in pregnancy in a state women’s prison facility
Knittel, A. K., Zarnick, S., Thorp, J. M., Amos, E., & Jones, H. E. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108159 · Cited by 17
Self-citation
Influence of Site Differences between Urban and Rural American and Central European Opioid-Dependent Pregnant Women and Neonatal Outcome Characteristics
Baewert, A., Jagsch, R., Winklbaur, B., Kaiser, G., Thau, K., Unger, A., Aschauer, C., Weninger, M., & Metz, V. E. (2012) · European Addiction Research · doi:10.1159/000335082 · Cited by 16
The management of opioid dependence during pregnancy in rural and remote settings
Jumah, N. A., Graves, L. E., & Kahan, M. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.131723 · Cited by 16
Investigating Mechanisms of Stillbirth in the Setting of Prenatal Substance Use
Miller, C. B., & Wright, T. E. (2018) · Academic Forensic Pathology · doi:10.1177/1925362118821471 · Cited by 15
Precision dosing of methadone during pregnancy: A pharmacokinetics virtual clinical trials study
Badhan, R. K. S., & Gittins, R. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108521 · Cited by 15
Trends in Injection Drug Use Among Pregnant Women Admitted into Drug Treatment: 1994–2006
Terplan, M., Smith, E. J., & Glavin, S. H. (2010) · Journal of Women s Health · doi:10.1089/jwh.2009.1562 · Cited by 15
Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates
Leeman, L. M., Brown, S. A., Albright, B. B., SKIPPER, B. J., Hsi, A., & Rayburn, W. F. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2010.536863 · Cited by 15
Medications for opioid use disorder during pregnancy: Access and continuity in a state women’s prison facility, 2016–2019
Knittel, A. K., Swartzwelder, R. A., Zarnick, S., Tsujimoto, T. H. M., Horne, T., Lin, F., Edwards, J., Amos, E., Alexander, J. M., Thorp, J. M., et al. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109308 · Cited by 14
Self-citation
What's in an “ASAM-based Assessment?” Variations in Assessment and Level of Care Determination in Systems Required to Use ASAM Patient Placement Criteria
Padwa, H., Mark, T. L., & Wondimu, B. B. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000804 · Cited by 14
Substance Use Disorder
Mahoney, K., Reich, W., & Urbanek, S. (2019) · MCN The American Journal of Maternal/Child Nursing · doi:10.1097/nmc.0000000000000551 · Cited by 14
Improved Maternal and Infant Outcomes with Serial, Self-Reported Early Prenatal Substance Use Screening
BODEN, S. L., Jones, C., & Cabacungan, E. (2021) · Maternal and Child Health Journal · doi:10.1007/s10995-021-03127-1 · Cited by 13

Authors: Jones, H. E., Martin, P. R., Heil, S. H., Kaltenbach, K., Selby, P., Coyle, M. G., Stine, S. M., O'Grady, K. E., Arria, A. M., & Fischer, G.
Affiliations: Vanderbilt University (US)
University of Vermont (US)
Thomas Jefferson University (US)
University of Toronto (CA)
Brown University (US)
Wayne State University (US)
University of Maryland, College Park (US)
Medical University of Vienna (AT)
ORCID: Martin, Peter R.
Heil, Sarah H.
Selby, Peter
Coyle, Mara G.
Stine, Susan M.
Arria, Amelia M.
Fischer, Gabriele
Venue: Journal of Substance Abuse Treatment
Publisher: Elsevier BV
Published: 2008-10
Volume: 35
Issue: 3
Pages: 245-259
ISSN: 0740-5472 (ISSN-L)
DOI: 10.1016/j.jsat.2007.10.007
PMC: PMC2633026
OpenAlex: W2094830932
Cited by: 191
References: 137
Citations by year: 2026: 4 · 2025: 9 · 2024: 10 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 12 · 2019: 16 · 2018: 16 · 2017: 10 · 2016: 4 · 2015: 8 · 2014: 9 · 2013: 8 · 2012: 16
FWCI: 2.50
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Journal of Substance Abuse Treatment (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Rice University
University of Vermont
Universität Wien
National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA015764, R01DA 0184103, R01DA015713, R01DA 0175138, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
National Center for Research Resources (M01RR000095, M01RR000109, M01-RR-00095)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords: opioid use disorder, pregnancy, maternal opioid treatment, methadone, buprenorphine, neonatal outcomes, induction, stabilization, pain management, breastfeeding, follow-up care, psychiatric comorbidity, drug interactions, clinical decision-making
MeSH terms: Analgesics, Opioid, Buprenorphine, Clinical Trials as Topic, Decision Making, Female, Humans, Infant, Newborn, Methadone, Opioid-Related Disorders, Pain, Pregnancy, Pregnancy Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Treatment of opioid-dependent pregnant women: Clinical and research issues

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks